Synthetic Biologics (SYN) Reports In-Line Q3 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. USO
2. CHRW
3. MRVL
4. SPY
5. RXO
6. OPCH
7. NVDA
8. APLD
9. AMD
10. HUBS

Go back to Synthetic Biologics (SYN) Reports In-Line Q3 EPS

Synthetic Biologics Reports Third Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET

November 3, 2021 4:10 PM EDT

ROCKVILLE, Md., Nov. 3, 2021 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal ("GI") diseases in areas of high unmet need, today provided a clinical programs update and reported financial results for the third quarter ended September 30, 2021.

... More